This trial is looking at how cancer drugs impact the vascular system and whether or not exercise can help offset some of those changes.
1 Primary · 15 Secondary · Reporting Duration: T1 (baseline), T2 (18-24 weeks), and T3 (12 months)
Active Control
80 Total Participants · 2 Treatment Groups
Primary Treatment: Taking Charge during Treatment (TCT) Intervention · No Placebo Group · N/A
Age 18 - 100 · Female Participants · 6 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: